Complete Digestive Stool Analysis (CDSA)
The Complete Digestive Stool Analysis (CDSA) is a functional test that provides an overview of the components of digestion, absorption, intestinal function and microbial flora, as well as identifying pathogenic bacteria, parasites and yeasts.
The CDSA is a non-invasive test providing invaluable information for the patient and practitioner in terms of understanding the role of poor digestive function in disease states.
Poor digestive function and imbalanced gut flora may play a crucial role in the underlying cause of a number of health conditions. Symptoms such as constipation, diarrhoea, flatulence, bloating, abdominal discomfort and bad breath may all indicate poor gut function.
Intestinal Permeability (IP)
The Intestinal Permeability (IP) test, also referred to as a “leaky gut” test, is a precise and non-invasive method for assessing gastrointestinal mucosal integrity.
Damage to the lining of the gastrointestinal tract (small and large intestine) is common in people with conditions such as food sensitivity and food allergy, irritable bowel syndrome, Crohn’s disease, arthritis, coeliac disease and dermatological conditions such as eczema, psoriasis and acne.
The lining of the gut wall is often subjected to a wide variety of insults from substances such as alcohol, caffeine, spices, medicines and environmental chemicals. The impact of chronic stress may also affect the permeability of the gut wall over time. Correcting the altered permeability may have an immediate effect on the relief of symptoms and facilitate the gradual improvement in the underlying condition.
Secretory IgA (sIgA)
Secretory Immunoglobulin A (sIgA) found in saliva, gastric fluids, plasma and the mucous membranes of the body, provides the main immunological defence of mucosal surfaces against pathogenic invasion.
It is thought to be representative of the functional status of the entire mucosal immune system. Stress has a major impact on the output of sIgA and maintaining a high daily production is essential for an adaptive immune response. It is thought that sIgA may provide a link between gut-related health conditions and systemic illness and is usually associated with altered intestinal permeability.
Investigation of salivary sIgA is recommended in food sensitivity, allergy, atopic conditions such as asthma and eczema, inflammatory bowel disease, irritable bowel syndrome and chronic infection.
Functional Liver Detoxification Profile (FLDP)
The Functional Liver Detoxification Profile (FLDP) challenges the liver’s Phase I and Phase II detoxification capacity with low doses of Caffeine, Aspirin and Paracetamol. Saliva and urine specimens, collected at timed intervals, are then analysed for metabolites of the three compounds to determine the efficiency of the liver in their conversion and clearance from the body.
The results of an FLDP will support accurate identification of the individual’s detoxification profile and assist in the direction of treatment.
The FLDP may particularly provide valuable information in the management of patients who suffer from food allergies, multiple chemical sensitivities, chronic fatigue syndrome, “leaky gut” and hormonal imbalance eg. premenstrual syndrome and menopausal symptoms.